Skip to main content

Media

Stay up-to-date with Roche's latest news, events and announcements.

  • Media events

    Never miss out on past and upcoming Roche events

  • Media statements

    Get access to the latest Roche media statements

  • Subscribe to Roche news

    Get the latest news and updates to your inbox

+11%

Core earnings per share growth at Constant Exchange Rates in 2025 (Core EPS 19.46 CHF - diluted)

39 million

patients were treated with Roche medicines in 2025

31 billion

Roche Diagnostic tests were delivered to customers worldwide in 2025

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Portrait of Thomas Schinecker

Dr Thomas Schinecker

CEO Roche Group

Roche’s Annual Report 2025

Discover how we're revolutionalising patient care in our 2025 Annual Report. Focused on innovation, research, sustainability, and strategic partnerships, with insights into our groundbreaking approaches.

Learn more

Microscopic image showing glowing blue cells clustered amidst intricate golden brown network, emitting a vibrant and scientific atmosphere.

Media contacts

Do you need to get in touch with us? Reach out to our media team with your enquiries.

In the spotlight

See all stories

Discover more

About Roche

About Roche

We unite leading science and technology across diagnostics, medicines, and digital solutions to prevent, stop and cure diseases.

Our strategy

About Roche

Keeping patients at the heart of everything we do, our ambition is clear: to prevent, stop, and cure diseases, improving outcomes and reducing costs for patients and healthcare systems worldwide.

Investors

Investors

We are committed to delivering value for all our stakeholders through continuous innovation, groundbreaking solutions, trust and sustainable business practices.